Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2000
11/23/2000WO2000041671A3 Composition, device, and method for subcutaneous fat removal
11/23/2000WO2000040232A3 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
11/23/2000WO2000037067A9 Sensitizing agents for the treatment of skin lesions
11/23/2000WO2000037045B1 Stabilized water-in-oil-in-water antigen delivery system
11/23/2000WO2000033812A3 Transdermal patch for delivering volatile liquid drugs
11/23/2000WO2000030626A3 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
11/23/2000WO2000030617A9 Taste masking rapid release coating system
11/23/2000WO2000027430A3 Composition consisting of influenza virus surface proteins and dispensing device
11/23/2000WO2000027365A9 Functionalized nanocrystals and their use in detection systems
11/23/2000WO2000022909A3 Systems for oral delivery
11/23/2000WO2000019978A3 Compositions and methods for enhancing receptor-mediated cellular internalization
11/23/2000WO2000016746A3 Immunogenic liposome compositions
11/23/2000WO2000012127A3 Dna cancer vaccine and methods for its use
11/23/2000DE19923829A1 Complex of hyaluronate, active ingredient and water, useful as topical pharmaceutical or cosmetic composition, is stable and has high content of active agent
11/23/2000DE19923817A1 Capsule with controlled active ingredient release comprises active ingredient-containing filling, capsule shell, swelling agent and water-insoluble layer
11/23/2000DE19923427A1 Device for improved delivery of active agents to skin, useful e.g. for administering opiates, contains agent that increases local skin temperature or blood flow
11/23/2000DE10024788A1 Substance for increasing an immune response during vaccinations or for increasing the production of antibodies, comprises solid lipid particles of a specific size and charge
11/23/2000DE10020499A1 Allgemeines Mehrschrittprotokoll zur therapeutischen Behandlung General multi-step protocol for therapeutic treatment
11/23/2000CA2767116A1 Adjuvant combination formulations
11/23/2000CA2373681A1 Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
11/23/2000CA2373629A1 Transdermal therapeutic system (tts) containing tolterodine
11/23/2000CA2373486A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372919A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
11/23/2000CA2372435A1 Recombinant human mannan-binding lectin
11/23/2000CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000CA2371551A1 Pharmaceutical compositions comprising apocodeine and/or its derivatives
11/23/2000CA2370066A1 Thiazolopyrimidines useful as tnf.alpha. inhibitors
11/23/2000CA2369397A1 Combined approach to treatment of cancer with hcg vaccines
11/23/2000CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects
11/23/2000CA2368593A1 Anti-inflammatory therapy for inflammatory mediated infection
11/22/2000EP1053753A1 Drug carrier for local use
11/22/2000EP1053752A1 Preparations with controlled release
11/22/2000EP1053747A2 Composition for treating topical periodontal infection
11/22/2000EP1053746A1 Use of biodegradable microspheres for the delivery of a anticancer agent for the treatment of glioblastoma
11/22/2000EP1053743A1 Composition for the treatment of halitosis
11/22/2000EP1053282A1 Acid-stable and cationic-compatible cellulose compositions and methods of preparation
11/22/2000EP1053277A1 Composite particles containing an active substance
11/22/2000EP1053030A2 Supporting material for medicinal purposes
11/22/2000EP1053029A1 Sterile complex of therapeutic peptide bond to a polysaccharide
11/22/2000EP1053024A1 Liposome fusion and delivery vehicle
11/22/2000EP1053023A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
11/22/2000EP1053022A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
11/22/2000EP1053020A1 Absorbable microparticles
11/22/2000EP1053011A1 Mixed micellar pharmaceutical delivery system and method of preparation
11/22/2000EP1053010A1 Copolymer compositions for oral delivery
11/22/2000EP1053002A1 Treatment of bony defects with osteoblast precursor cells
11/22/2000EP1052995A1 Pharmaceutical composition for nasal administration of thiocolchicoside
11/22/2000EP1052987A1 Tablets to be crunched or sucked, comprising iron as active principle
11/22/2000EP1052985A1 Pharmaceuticals comprising n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid for iron chelating therapy
11/22/2000EP1052979A1 Device for releasing substances
11/22/2000EP1052978A1 Encapsulation system with organic core and mineral cortex based on aluminium hydroxycarbonate and preparation method
11/22/2000EP1052977A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
11/22/2000EP1052976A1 Method for ultrasound triggered drug delivery
11/22/2000EP1052975A1 Propofol composition containing sulfite
11/22/2000EP1052974A2 Compositions containing organic compounds
11/22/2000EP1052973A1 Transmucosal formulations of levosimendan
11/22/2000EP1052964A1 Cosmetic composition containing an aqueous dispersion of insoluble polymer material particles, use and method
11/22/2000EP0725637B1 Parenteral busulfan for treatment of malignant disease
11/22/2000EP0722327B1 Improvements relating to antibacterial compositions
11/22/2000EP0705255B1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes
11/22/2000EP0701443B2 Terfenadine metabolites and their optically pure isomers for treating allergic disorders
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274289A Compsns. comprising comjugates of stable, active, human ob protein with antibody FC chain and methods
11/22/2000CN1274286A Parenteral formulations comprising carbamazepine or its derivatives
11/22/2000CN1274280A Delayed total release gastrointestinal drug delivery system
11/22/2000CN1274279A Film-coated tablet for improved upper gastrointestinal tract safety
11/22/2000CN1274278A Powdery aerosol preparation
11/22/2000CN1273861A Low sustituted ethylene-lactic cellulose and solid preparation
11/22/2000CN1273855A Process for preparing medicinal pills for treating hepatitis B
11/22/2000CN1273844A Process fr preparing Wugongtougu oil
11/22/2000CN1273837A Black ointment
11/22/2000CN1273824A Exterior-applied medicine containing phosphonomycin calcium and its application
11/22/2000CN1273820A Process for preparing Chinese-medicinal pills containing borneol
11/22/2000CN1273819A Release-controlled Chinese-medicinal picking for reducing baby fever caused by cold
11/22/2000CN1273818A Process for preparing micro pills containing medicine by high-speed stirring and fusion
11/22/2000CN1273817A Process for granulating pure eucommia bark powder
11/22/2000CN1273785A Process for preparing freeze-dried royal jelly tablets
11/22/2000CN1058706C Prostaglandin derivative
11/22/2000CN1058627C Compound arnebia root paste for curing heat injury of human body and its preparing method
11/22/2000CN1058623C Anti-hepatitis B capsule
11/22/2000CN1058621C External-use ointment for treating bone tuberculosis
11/22/2000CN1058620C External-use Chinese patent drug for treating cancer, and its prodn. tech.
11/22/2000CN1058619C Antiphlogistic analgesic ointment for treating burn
11/22/2000CN1058618C Traditional Chinese medicinal prepn. for relieving swelling and alleviating pain of throat, and its prodn. method
11/22/2000CN1058613C Ointment for resolving blood stasis and prepn. method
11/22/2000CN1058608C Method of medicinal compsns. fed by non-galenic form
11/21/2000US6150505 Preparing aqueous solution of fibrinogen, thrombin and factor xiii, before coagulation adding an oil heated to 50-80 degrees celsius to form emulsion, mixing until crosslinked microbeads are formed, isolating beads; glutaraldehyde-free
11/21/2000US6150425 Comprising an outer phase oil and oil in water emulsion in the inner phase which containing water, an oil based ingredient, a surfactant and an amphiphilic substance; prepared by a high pressure or ultrasonic emulsification
11/21/2000US6150424 Comprising a melt-processable thermoplastic polymer and a volatile, physiologically acceptable blowing agent
11/21/2000US6150422 Stable gelled composition containing lipophilic active agents sensitive to oxygen and/or water
11/21/2000US6150420 By administering buproprion or salt and carrier intranasally; treating nicotine addiction, depression
11/21/2000US6150418 Propellant-free concentrate suitable for storage containing given concentration of formoterol, or salt or addition products thereof as active substance in a solvent or suspension agent; use in inhalation therapy
11/21/2000US6150410 Acidic drug such as divalproex sodium dissolved or dispersed in a polymeric matrix of a neutral, water-swellable, hydrophilic polymer, and acid soluble polymer water swellable above ph 5; uniform release in stomach and intestines
11/21/2000US6150407 In a tissue or organ by contacting with a compound of given formula such as methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate; reducing the level of tumor necrosis factor alpha
11/21/2000US6150400 Method for treating vulvar vestibulitis
11/21/2000US6150396 Methods of treating or preventing interstitial cystitis
11/21/2000US6150384 Pharmaceutical composition
11/21/2000US6150383 Comprising an insulin sensitivity enhancer in combination with one or more other antidiabetics differing from the enhancer in mechanism of action; lipid/glycometabolism disorders; antidiabetic agents; side effect reduction
11/21/2000US6150380 Crystalline form of omeprazole
1 ... 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 ... 2991